Company Day One Biopharmaceuticals, Inc.
Equities
DAWN
US23954D1090
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.27 USD | -2.43% | -3.63% | -9.11% |
May. 30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
May. 20 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
Business Summary
Number of employees: 174
Managers
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 18-10-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Charles York
DFI | Director of Finance/CFO | 47 | 21-01-31 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 22-09-30 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 23-04-30 |
Jaa Roberson
HRO | Human Resources Officer | - | 21-09-12 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 23-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 21-08-16 |
Natalie Holles
BRD | Director/Board Member | 51 | 21-01-31 |
John Josey
BRD | Director/Board Member | 63 | 20-08-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director/Board Member | 37 | 19-11-30 | |
Director/Board Member | 48 | 21-02-28 | |
William Grossman
BRD | Director/Board Member | 54 | Jan. 16 |
Garry Nicholson
CHM | Chairman | 69 | 22-09-11 |
Habib Dable
BRD | Director/Board Member | 54 | Jan. 16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 87,389,859 | 70,160,882 ( 80.28 %) | 0 | 80.28 % |
Company contact information
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 1.16B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- DAWN Stock
- Company Day One Biopharmaceuticals, Inc.